Intensivmedizin up2date, Table of Contents Intensivmedizin up2date 2013; 09(03): 217-231DOI: 10.1055/s-0033-1344623 Allgemeine Prinzipien der Intensivmedizin © Georg Thieme Verlag KG Stuttgart · New York Endokrinologie der Intensivmedizin Björn Ellger , Ingeborg van den Heuvel , Antje Gottschalk Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Habib KE, Gold PW, Chrousos GP. Neuroendocrinology of stress. Endocrinol Metab Clin North Am 2001; 30: 695-728 2 Van den Berghe BG. The neuroendocrine response to stress is a dynamic process. Best Pract Res Clin Endocrinol Metab 2001; 15: 405-419 3 Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001; 15: 533-551 4 Langouche L, Vander Perre S, Marques M et al. Impact of early nutrient restriction during critical illness on the nonthyroidal illness syndrome and its relation with outcome: a randomized, controlled clinical study. J Clin Endocrinol Metab 2013; 98: 1006-1013 5 Fan Y, Zhang AM, Xiao YB et al. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: A meta-analysis. Eur J Cardiothorac Surg 2011; 40: 192-199 6 Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367 7 Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-461 8 Vlasselaers D, Milants I, Desmet L et al. Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009; 373: 547-556 9 Vanhorebeek I, Langouche L. Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: Glucose versus insulin. Best Pract Res Clin Anaesthesiol 2009; 23: 449-459 10 NICE-SUGAR Study Investigators. Finfer S, Chittock DR et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297 11 Ellger B, Van den Berghe G. Tight glycaemic control: From bed to bench and back. Best Pract Res Clin Anaesthesiol 2009; 23: VII-IX 12 Preiser JC, Devos P, Chiolero R. Which factors influence glycemic control in the intensive care unit?. Curr Opin Clin Nutr Metab Care 2010; 13: 205-210 13 Siegelaar SE, Devries JH, Hoekstra JB. Patients with diabetes in the intensive care unit; not served by treatment, yet protected?. Critical Care 2010; 14: 126-127 14 Egi M, Bellomo R, Stachowski E et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105: 244-252 15 Vogelzang M, Loef BG, Regtien JG et al. Computer-assisted glucose control in critically ill patients. Intensive Care Med 2008; 34: 1421-1427 16 Wahl HG. How accurately do we measure blood glucose levels in intensive care unit (ICU) patients?. Best Pract Res Clin Anaesthesiol 2009; 23: 387-400 17 Duning T, Ellger B. Is hypoglycaemia dangerous?. Best Pract Res Clin Anaesthesiol 2009; 23: 473-485 18 Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med 2007; 35: 2262-2267 19 Duning T, van den Heuvel I, Dickmann A et al. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care 2010; 33: 639-644 20 Nobels F, Lecomte P, Deprez N et al. Tight glycaemic control: Clinical implementation of protocols. Best Pract Res Clin Anaesthesiol 2009; 23: 461-472 21 Mesotten D, Van den Berghe G. Glycemic targets and approaches to management of the patient with critical illness. Curr Diab Rep 2012; 12: 101-107 22 Van den Berghe BG, Baxter RC, Weekers F et al. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 2002; 56: 655-669 23 Elijah IE, Branski LK, Finnerty CC et al. The GH/IGF-1 system in critical illness. Best Pract Res Clin Endocrinol Metab 2011; 25: 759-767 24 Taylor BE, Buchman TG. Is there a role for growth hormone therapy in refractory critical illness?. Curr Opin Crit Care 2008; 14: 438-444 25 Mebis L, Van den Berghe G. Thyroid axis function and dysfunction in critical illness. Best Pract Res Clin Endocrinology Metab 2011; 25: 745-757 26 Barquist E, Kirton O. Adrenal insufficiency in the surgical intensive care unit patient. J Trauma 1997; 42: 27-31 27 Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA 2002; 287: 236-240 28 Pappa TA, Vagenakis AG, Alevizaki M. The nonthyroidal illness syndrome in the non-critically ill patient. Eur J Clin Invest 2011; 41: 212-220 29 Venkatesh B, Cohen J. Adrenocortical (dys)function in septic shock – a sick euadrenal state. Best Pract Res Clin Endocrinol Metab 2011; 25: 719-733 30 Gibbison B, Angelini GD, Lightman SL. Dynamic output and control of the hypothalamic-pituitary-adrenal axis in critical illness and major surgery. Br J Anaesth 2013;
